All Stories

  1. Mechanobiology of non-small cell lung cancer: bridging tumor mechanics and therapeutic strategies
  2. DoE-Optimized Chitosan-Coated pH-Sensitive Liposomes for Targeted Nose-to-Brain Delivery of Temozolomide
  3. Bilayered dissolving microneedles for microemulsion-mediated ocular delivery of brimonidine tartrate in glaucoma therapy
  4. Biomimetic oral drug delivery: Translating nature’s design into therapeutic innovation
  5. Enhanced Ocular Delivery of Bimatoprost Using Surfactant and Lipid-Based Bilosomes in Situ Gel in Rabbits and Glaucoma-Induced Wistar Rats
  6. Enhanced Breast Cancer Therapy using TPGS-Functionalized PLGA Nanoparticles: a 3D Spheroid Tumor Model Approach
  7. Efficient Co‐Loading of Paclitaxel and Gefitinib in PLGA Nanoparticles: Use of Design of Experiments ( DoE ) Approach for Enhanced Efficacy Against ...
  8. Design and comparative evaluation of liposomes and ultra-flexible combisomes incorporating stratum corneum lipids for the delivery of 4-hydroxytamoxifen and thymoquinone
  9. Bridging Therapeutic Strategies in Triple-Negative Breast Cancer: Integrating Combination therapies, Antibody-drug conjugates, and Nanocarriers
  10. Recent Advances in Nanocarrier Systems for the Co-Delivery of siRNA and Chemotherapeutic Drug for Breast Cancer Therapy
  11. Bionanocomposites in Nasal Drug Delivery
  12. Hyaluronic acid-coated cubosomal in situ gel for Brimonidine Tartrate: a sustained delivery system with enhanced ocular bioavailability and intraocular pressure reduction
  13. Breaking the Barrier: Enhanced Transdermal Benztropine Delivery Using Nanoparticle-loaded Dissolving Microneedles
  14. Chitosan-based copolymeric nanocarrier systems: A novel paradigm for targeted breast cancer therapy
  15. Therapeutic evaluation of paclitaxel co-loaded PLGA nanoparticles with imatinib, protamine-imatinib, and gefitinib: comparative in vitro studies in MDA-MB-231 breast cancer cells and in vivo investigations in rats
  16. Bilosomes as a novel ocular drug delivery system: Assessing the material attributes, process parameters, and quality attributes
  17. Efficient nose-to-brain delivery of chitosan-coated resveratrol nanoemulsion in rats: Formulation optimized using D-optimal mixture design
  18. Next-gen cancer therapy: The convergence of artificial intelligence, nanotechnology, and digital twin
  19. Matrix formers
  20. Functional polymeric coatings for immediate release dosage forms
  21. Electrospun nanofiber-based drug delivery system
  22. Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS
  23. Nanofiber power: Reinforcing in-situ hydrogel for enhanced rivastigmine delivery
  24. Quality by design steered approach for co-encapsulation of timolol maleate and dorzolamide hydrochloride in injectable liposomes
  25. PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells
  26. Advances in drug-loaded contact lenses for glaucoma: Materials, evaluation parameters, and novel drug delivery strategies with modified nanoparticles
  27. Self-nano-emulsifying Drug Delivery Systems of Atorvastatin Calcium Liquid Filled in Hard Shell Capsules for Improved Oral Bioavailability in Rabbits
  28. A Review on Nanostructured Lipid Carriers as Promising Drug Delivery Vehicle to Target Various Cancers via Oral Route: A Step towards “Chemotherapy at Home”
  29. QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells
  30. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles
  31. Temozolomide nano-in-nanofiber delivery system with sustained release and enhanced cellular uptake by U87MG cells
  32. Biopolymers, Composites, Nanocomposites, and Gels in Biotechnology
  33. Emerging drug delivery systems to alter tumor immunosuppressive microenvironment: Overcoming the challenges in immunotherapy for glioblastoma
  34. Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment
  35. Fragmented antibodies in non-small cell lung cancer: A novel nano-engineered delivery system for detection and treatment of cancer
  36. Bimatoprost-Loaded Lipidic Nanoformulation Development Using Quality by Design: Liposomes Versus Solid Lipid Nanoparticles in Intraocular Pressure Reduction
  37. Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells
  38. Quality by Design (QbD) enabled and Box-Behnken design assisted approach for formulation of tranexamic acid loaded stratum corneum lipid liposomes
  39. Application of quality by design approach to examine the effect of nanocrystalline cellulose extracted from agricultural waste as a disintegrant
  40. Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders
  41. PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability
  42. Methods for encapsulation of hydrophilic drugs in nanocarriers
  43. Biobased materials in nano drug delivery
  44. Impact of biobased materials on drug delivery for improved cancer therapy
  45. Quantum dots in diagnostic imaging
  46. Doxorubicin Hydrochloride-loaded Nanoparticles for Oral Delivery: Optimization using Design of Experiments
  47. Long circulating polymeric nanoparticles of gemcitabine HCl using PLGA-PEG-PPG-PEG block co-polymer
  48. Formulation and evaluation of polymer-coated bimatoprost-chitosan matrix ocular inserts for sustained lowering of IOP in rabbits
  49. Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications
  50. Nanoparticles incorporated in nanofibers using electrospinning: A novel nano-in-nano delivery system
  51. Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy
  52. Bimatoprost: Promising novel drug delivery systems in treatment of glaucoma
  53. Liquid Filled Hard Shell Capsules: Current Drug Delivery Influencing Pharmaceutical Technology
  54. Formulation and evaluation of brinzolamide encapsulated niosomal in-situ gel for sustained reduction of IOP in rabbits
  55. Nanomaterials physics: A critical review
  56. Applications of surfactin and other biosurfactants in anticancer activity
  57. Erlotinib Hydrochloride Novel Drug Delivery Systems: A Mini Review Unravelling the Role of Micro- and Nanocarriers
  58. Quality by Design Approach for Development and Optimization of Rifampicin Loaded Bovine Serum Albumin Nanoparticles and Characterization
  59. Road map to the treatment of neglected tropical diseases: Nanocarriers interventions
  60. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy
  61. Formulation Development and Evaluation of Fast Dissolving Films of Oloptadine HCl
  62. Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer
  63. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device
  64. Fabrication and characterization of polycaprolactone-based green materials for drug delivery
  65. Polylactic coglycolic acid (PLGA)-based green materials for drug delivery
  66. Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers)
  67. Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I
  68. Potentiality of Q3 characterization of nanosystem: Surrogate data for obtaining a biowaiver
  69. Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles
  70. An outlook on procedures of conjugating folate to (co)polymers and drugs for effective cancer targeting
  71. QbD based approach for formulation development of spray dried microparticles of erlotinib hydrochloride for sustained release
  72. Unfolding the electrospinning potential of biopolymers for preparation of nanofibers
  73. Formulations for Polymer Coatings
  74. Application of Electrospun Materials in Gene Delivery
  75. Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer
  76. Nanogels in Medicine
  77. Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
  78. Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
  79. High Pressure Homogenizer in Pharmaceuticals: Understanding Its Critical Processing Parameters and Applications
  80. Understanding the biology and advent of physics of cancer with perspicacity in current treatment therapy
  81. Applications of microneedles in delivering drugs for various ocular diseases
  82. Development and Validation of UV-Spectrophotometric Method for Estimation of Irbesartan by the Hydrotrophy Technique
  83. Implantable drainage devices in glaucoma: Quo vadis?
  84. Design of Experiments (DoE) Approach to Optimize the Sustained Release Microparticles of Gefitinib
  85. E-drug delivery: a futuristic approach
  86. Glaucoma: Current treatment and impact of advanced drug delivery systems
  87. Polymers, responsiveness and cancer therapy
  88. Levels of Drug Targeting
  89. COMPARATIVE QUALITATIVE AND QUANTITATIVE PHYTOCHEMICAL ANALYSIS OF CALOTROPIS GIGANTEA AND CALOTROPIS PROCERA ROOTS
  90. Nanocomposite for cancer targeted drug delivery
  91. Nanogels as Targeted Drug Delivery Vehicles
  92. Standardization of roots of Calotropisprocera and Calotropis gigantean via evaluation of morphological and physicochemical parameters
  93. Communication of Drug Loaded Nanogels with Cancer Cell Receptors for Targeted Delivery
  94. An updated Review on Phytochemistry, Pharmacological activity and Medicinal uses of Calotropis gigantea R. Br.
  95. Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art
  96. Inhaled Formulation Design for the Treatment of Lung Infections
  97. Fast-Dissolving Films of Sumatriptan Succinate: Factorial Design to Optimize In Vitro Dispersion Time
  98. Applications of nanoparticles in treatment and diagnosis of leukemia
  99. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide
  100. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia
  101. Intracellular Delivery of Etoposide Loaded Biodegradable Nanoparticles: Cytotoxicity and Cellular Uptake Studies
  102. Modified Nanoprecipitation Method for Preparation of Cytarabine-Loaded PLGA Nanoparticles
  103. Long circulating nanoparticles of etoposide using PLGA-MPEG and PLGA-pluronic block copolymers: characterization, drug-release, blood-clearance, and biodistribution studies
  104. Formulation Optimization of Etoposide Loaded PLGA Nanoparticles by Double Factorial Design and their Evaluation
  105. Nimodipine Loaded PLGA Nanoparticles: Formulation Optimization Using Factorial Design,Characterization and In Vitro Evaluation